Sofinnova Capital VII FCPR 13D and 13G filings for ShockWave Medical, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2020-09-14 3:44 pm Sale | 2020-08-17 | 13D | ShockWave Medical, Inc. SWAV | Sofinnova Capital VII FCPR | 1,694,206 4.980% | -585,623 (-25.69%) | Filing |
| 2020-08-18 8:31 pm Sale | 2020-06-01 | 13D | ShockWave Medical, Inc. SWAV | Sofinnova Capital VII FCPR | 2,279,829 7.160% | -1,114,377 (-32.83%) | Filing |